Better Connect Patients with Therapies that Benefit Them

Conventional models of pharmaceutical commercialization are not well-suited for many chronic care medicines.  This limits the ability of patients to benefit from medicines that can improve their quality of life.

Our vision is to reduce the cost of commercialization so that patients who may benefit from an approved therapy have the opportunity to speak with a well-informed physician about treatment options.